loading
前日終値:
$7.18
開ける:
$7.23
24時間の取引高:
5,031
Relative Volume:
0.16
時価総額:
$13.72M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-6.29%
1か月 パフォーマンス:
-14.12%
6か月 パフォーマンス:
+42.02%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$7.1504
$7.307
1週間の範囲:
Value
$6.815
$7.99
52週間の値動き範囲:
Value
$2.90
$12.55

Neuphoria Therapeutics Inc Stock (NEUP) Company Profile

Name
名前
Neuphoria Therapeutics Inc
Name
セクター
Healthcare (1158)
Name
電話
781-439-5551
Name
住所
100 SUMMIT DR, BURLINGTON
Name
職員
24
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
NEUP's Discussions on Twitter

NEUP を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
NEUP
Neuphoria Therapeutics Inc
7.30 14.64M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
390.00 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
575.46 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
445.81 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
685.36 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
311.20 37.96B 3.81B -644.79M -669.77M -6.24

Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-09-28 アップグレード H.C. Wainwright Neutral → Buy
2023-09-28 繰り返されました Maxim Group Buy
2022-01-10 開始されました Berenberg Buy
2022-01-10 開始されました Cantor Fitzgerald Overweight
2022-01-10 開始されました Evercore ISI Outperform
2022-01-10 開始されました H.C. Wainwright Buy
すべてを表示

Neuphoria Therapeutics Inc (NEUP) 最新ニュース

pulisher
Aug 20, 2025

Volatility clustering patterns for Neuphoria Therapeutics Inc.Gap Down & Fast Moving Stock Watchlists - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Sentiment analysis tools applied to Neuphoria Therapeutics Inc.July 2025 Volume & High Accuracy Swing Entry Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Chart based exit strategy for Neuphoria Therapeutics Inc.Quarterly Portfolio Report & Long-Term Investment Growth Plans - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Exit strategy if you’re trapped in Neuphoria Therapeutics Inc.July 2025 Breakouts & Capital Protection Trading Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Is Neuphoria Therapeutics Inc. reversing from oversold territoryFed Meeting & Low Drawdown Trading Strategies - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Is it too late to sell Neuphoria Therapeutics Inc.2025 Price Action Summary & Free Long-Term Investment Growth Plans - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Is Neuphoria Therapeutics Inc. stock entering bullish territoryNew Guidance & Free Accurate Trade Setup Notifications - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

How to build a dashboard for Neuphoria Therapeutics Inc. stockPortfolio Gains Summary & Target Return Focused Stock Picks - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Can momentum traders help lift Neuphoria Therapeutics Inc.Risk Management & Daily Profit Maximizing Tips - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Statistical indicators supporting Neuphoria Therapeutics Inc.’s strengthJuly 2025 News Drivers & Intraday High Probability Setup Alerts - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

What to expect from Neuphoria Therapeutics Inc. in the next 30 daysPortfolio Growth Summary & Fast Gaining Stock Strategy Reports - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Identifying reversal signals in Neuphoria Therapeutics Inc.2025 Stock Rankings & Free AI Powered Buy and Sell Recommendations - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Will breakout in Neuphoria Therapeutics Inc. lead to full recoveryProfit Target & Free High Return Stock Watch Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Neuphoria Therapeutics Inc. stock trend outlook and recovery path2025 Risk Factors & Consistent Profit Trading Strategies - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Analyzing Neuphoria Therapeutics Inc. with multi timeframe charts2025 Major Catalysts & Technical Entry and Exit Tips - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

What momentum shifts mean for Neuphoria Therapeutics Inc.CPI Data & AI Powered Buy and Sell Recommendations - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

How hedge fund analytics apply to Neuphoria Therapeutics Inc. stock2025 Growth vs Value & Fast Exit and Entry Strategy Plans - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Neuphoria Therapeutics Inc. stock momentum explained2025 Support & Resistance & Momentum Based Trading Signals - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Forecasting Neuphoria Therapeutics Inc. price range with options dataPortfolio Risk Summary & Expert Curated Trade Setup Alerts - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Evaluating Neuphoria Therapeutics Inc. with trendline analysisPortfolio Growth Summary & Weekly Sector Rotation Insights - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

Will Neuphoria Therapeutics Inc. continue its uptrend2025 Performance Recap & Real-Time Chart Breakout Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

How to integrate Neuphoria Therapeutics Inc. into portfolio analysis tools2025 Support & Resistance & High Yield Stock Recommendations - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Published on: 2025-08-17 00:10:08 - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Why Neuphoria Therapeutics Inc. stock attracts strong analyst attentionEarnings Recap Summary & Daily Entry Point Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Analyzing drawdowns of Neuphoria Therapeutics Inc. with statistical toolsPortfolio Value Report & Free Accurate Trade Setup Notifications - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Live market analysis of Neuphoria Therapeutics Inc.Chart Signals & Fast Exit and Entry Trade Guides - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Is Neuphoria Therapeutics Inc.’s ROIC above industry averageJuly 2025 Review & Stepwise Entry/Exit Trade Alerts - 선데이타임즈

Aug 16, 2025
pulisher
Aug 15, 2025

Combining machine learning predictions for Neuphoria Therapeutics Inc.July 2025 Setups & Low Risk Profit Maximizing Plans - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

What MACD and RSI say about Neuphoria Therapeutics Inc.Inflation Watch & Target Return Focused Picks - Newser

Aug 15, 2025

Neuphoria Therapeutics Inc (NEUP) 財務データ

Neuphoria Therapeutics Inc (NEUP) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$24.50
price down icon 0.62%
$84.89
price down icon 0.05%
$26.23
price up icon 0.21%
$106.50
price down icon 3.97%
$130.38
price down icon 1.11%
biotechnology ONC
$310.97
price down icon 0.78%
大文字化:     |  ボリューム (24 時間):